HiDO Health’s device is different because it actually records patients taking their medications, a UC Davis researcher testing the tool says.

Morning Brew Inc., Photos: Adobe Stock, Unsplash
An estimated 94% of adults ages 65 and older are taking a prescription, according to KFF, but many struggle to take the right medications at the right time.
Memory issues can make adherence quite challenging for older adults, over 30% of whom have mild cognitive impairment or dementia, a 2022 Columbia University study found. And the consequences are jarring, as medication nonadherence in older adults has been linked to higher rates of hospitalizations.
There are many medical alert companies, like Medical Guardian and MobileHelp, that have created devices to help older adults manage medications. So Folsom, California-based health tech HiDO Health took a different route: adding in a camera for accountability purposes. Now, it’s connecting with UC Davis Health to test it with patients.
HiDO was co-founded in 2019 by CEO Charles Gellman, who was studying data science and clinical informatics and looking for data on how to keep patients out of the hospital. But he said it was hard to come by standardized real-world data on how patients were taking medications, and that’s what researchers would need to prove medication efficacy.
So while Gellman had “zero interest in medical devices,” he needed to build one to get the data he needed. He enlisted a team of engineers to create a medication disbursement tool, now known as the adherence HiDO Health HomeCcare System. Still, he never thought it would be used to help patients with memory care—until a friend approached him in 2021 about using it to help their mother-in-law who had dementia.
“That ultimately changed my mind—maybe we’re doing something a little bit more impactful than I originally anticipated,” Gellman said.
As of 2026, the company has raised $1.7 million in venture funding, according to PitchBook data. On Oct. 7, HiDO and UC Davis announced a clinical trial to collect real-world data by having patients with mild cognitive impairment and moderate dementia use HiDO’s device at home.
The research is funded by a $2.5 million National Institute on Aging grant that supports small business innovation. This is the second major partnership for the company, which previously worked with Rush University System for Health in Chicago to test the usability of the device with 35 patients in the clinic. All participants successfully finished at least one dispensing task, according to the study’s results, and the device received an above-average usability score.
“The idea is to eliminate medication errors from happening in the home,” Gellman said.
Innovations like HiDO’s are “promising,” Sheena Aurora, VP of medical affairs at the Alzheimer’s Association told us via email, but their success “ultimately depends on usability, privacy protections, and evidence that they improve real-world outcomes.”
Gellman thinks HiDO has unlocked this balance since the AI-enabled device requires minimal effort from the patient. All they have to do is put a standard pill bottle into the machine and a microchip will recognize the medication name, dosage, frequency, and count.
The other distinguisher of HiDO’s technology is its camera. Patients walk up to the device, unlock it with facial recognition technology, hit a confirmation button, and then a video records them taking the pills. Only approved caregivers and family members can see the patient’s log recorded by the system.
One of the researchers running the study, Alyssa Weakley, who is an assistant professor of neurology at UC Davis, specializes in developing and evaluating technologies for Alzheimer’s disease. She said she gets presented with devices all the time, but wanted to work with HiDO’s specifically because of its camera.
“There are automatic pill dispensers that are on the market that will let [providers or caregivers] know the medication has been removed, but there’s nothing that lets us know somebody actually ingested that medication,” she said. “That’s the big missing piece.”
Gellman said he wanted to work with UC Davis because its center for Alzheimer’s research is part of the Centers of Excellence—a network of 10 dementia care research institutes at university medical schools in California—and it has access to patients who may benefit from HiDO. Along with managing the clinical trial, the health system will also conduct training sessions with participants.
Hospitals are motivated to do these clinical trials because it’s important for technologies to be evaluated without bias, Weakley said.
“It is a rule for hospital-based systems that are university or academic environments to partner with technology companies to make sure that their technology actually delivers on the promises that they say,” she said. “There’s a lot of technologies that are developed and not ever rigorously evaluated.”
Clinical trials help assure patients and caregivers that they’re investing in the right tools that meet their needs, she added.